DCF — BAPTIST HEALTH LAGRANGE
Enterprise Value: $19.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$19.6M
Enterprise Value
$-0.4M
PV of Cash Flows
$20.0M
PV of Terminal Value
$32.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $244.0M | $7.8M | 3.0% | $-2.9M | $-2.7M |
| Year 2 | $251.3M | $10.6M | 4.0% | $-1.1M | $-0.9M |
| Year 3 | $258.9M | $13.5M | 5.0% | $0.8M | $0.6M |
| Year 4 | $266.7M | $15.2M | 6.0% | $1.8M | $1.2M |
| Year 5 | $274.7M | $16.4M | 6.0% | $2.4M | $1.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $19.6M. Terminal value accounts for 102% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$236.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02703248076884302
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5